ARPA-H awards up to $125M across 5 teams, including Waterfall Scientific, to build automated systems that can make personalized RNA medicines in under a week.
September 1, 2026 02:32 PM EDT
R&DCell/Gene TxManufacturing
ARPA-H awards $125M for manufacturing custom RNA therapies on demand
Ryan Cross
Senior Science Correspondent
ARPA-H taps 7 teams for up to $160M to build bespoke gene editing drugs, betting on Baby KJ's playbook — but some scientists say…
An ARPA-H program to jump-start custom gene editing treatments was delayed by a change in administrations. Now seven labs will…
The ARPA-H program could provide researchers with a roadmap to develop personalized gene editing drugs. Elsewhere, a Botox rival…
The Advanced Research Projects Agency for Health (ARPA-H) launched a $62.7 million effort to develop a patient-facing agentic…
ARPA-H invests $62.7M in ADVOCATE program; UpDoc, Tempus AI & Atman Health to build FDA-authorized AI tools for heart disease…
Children's Hospital of Philadelphia Secures Five-year, up to $38.9 Million ARPA‑H Award to Advance Personalized Gene Editing…
